Real-Time Super-Resolution Ultrasound Imaging for Monitoring Tumor Response During Intensive Care Management of Oncologic Emergencies.

IF 2.1 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Jinping Wu, Wentao Xu, Li Li, Wenqing Xie, Bei Tang
{"title":"Real-Time Super-Resolution Ultrasound Imaging for Monitoring Tumor Response During Intensive Care Management of Oncologic Emergencies.","authors":"Jinping Wu, Wentao Xu, Li Li, Wenqing Xie, Bei Tang","doi":"10.1177/10849785251376112","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Oncologic emergencies in critically ill cancer patients frequently require rapid, real-time assessment of tumor responses to therapeutic interventions. However, conventional imaging modalities such as computed tomography and magnetic resonance imaging are often impractical in intensive care units (ICUs) due to logistical constraints and patient instability. Super-resolution ultrasound (SR-US) imaging has emerged as a promising noninvasive alternative, facilitating bedside evaluation of tumor microvascular dynamics with exceptional spatial resolution. This study assessed the clinical utility of real-time SR-US imaging in monitoring tumor perfusion changes during emergency management in oncological ICU settings. <b><i>Methods:</i></b> In this prospective observational study, critically ill patients with oncologic emergencies underwent bedside SR-US imaging before and after the initiation of emergency therapy (e.g., corticosteroids, decompression, or chemotherapy). SR-US was employed to quantify microvascular parameters, including perfusion density and flow heterogeneity. Data processing incorporated artificial intelligence for real-time vessel segmentation and quantitative analysis. <b><i>Results:</i></b> SR-US imaging successfully detected perfusion changes within hours of therapy initiation. A significant correlation was observed between reduced tumor perfusion and clinical improvement, including symptom relief and shorter ICU stay. This technology enables visualization of microvessels as small as 30 µm, surpassing conventional ultrasound limits. No adverse events were reported with the use of contrast microbubbles. In addition, SR-US imaging reduces the need for transportation to radiology departments, thereby optimizing ICU workflow. <b><i>Conclusions:</i></b> Real-time SR-US imaging offers a novel, bedside-compatible method for evaluating tumor vascular response during the acute phase of oncological emergencies. Its integration into ICU care pathways could enhance timely decision-making, reduce reliance on static imaging, and support personalized cancer management. Further multicenter validation is required.</p>","PeriodicalId":55277,"journal":{"name":"Cancer Biotherapy and Radiopharmaceuticals","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Biotherapy and Radiopharmaceuticals","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10849785251376112","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Oncologic emergencies in critically ill cancer patients frequently require rapid, real-time assessment of tumor responses to therapeutic interventions. However, conventional imaging modalities such as computed tomography and magnetic resonance imaging are often impractical in intensive care units (ICUs) due to logistical constraints and patient instability. Super-resolution ultrasound (SR-US) imaging has emerged as a promising noninvasive alternative, facilitating bedside evaluation of tumor microvascular dynamics with exceptional spatial resolution. This study assessed the clinical utility of real-time SR-US imaging in monitoring tumor perfusion changes during emergency management in oncological ICU settings. Methods: In this prospective observational study, critically ill patients with oncologic emergencies underwent bedside SR-US imaging before and after the initiation of emergency therapy (e.g., corticosteroids, decompression, or chemotherapy). SR-US was employed to quantify microvascular parameters, including perfusion density and flow heterogeneity. Data processing incorporated artificial intelligence for real-time vessel segmentation and quantitative analysis. Results: SR-US imaging successfully detected perfusion changes within hours of therapy initiation. A significant correlation was observed between reduced tumor perfusion and clinical improvement, including symptom relief and shorter ICU stay. This technology enables visualization of microvessels as small as 30 µm, surpassing conventional ultrasound limits. No adverse events were reported with the use of contrast microbubbles. In addition, SR-US imaging reduces the need for transportation to radiology departments, thereby optimizing ICU workflow. Conclusions: Real-time SR-US imaging offers a novel, bedside-compatible method for evaluating tumor vascular response during the acute phase of oncological emergencies. Its integration into ICU care pathways could enhance timely decision-making, reduce reliance on static imaging, and support personalized cancer management. Further multicenter validation is required.

实时超分辨率超声成像在肿瘤急诊重症监护管理中监测肿瘤反应。
背景:危重癌症患者的肿瘤紧急情况经常需要快速、实时地评估肿瘤对治疗干预的反应。然而,由于后勤限制和患者不稳定,传统的成像方式,如计算机断层扫描和磁共振成像,在重症监护病房(icu)通常是不切实际的。超分辨率超声(SR-US)成像已成为一种有前途的非侵入性替代方法,有助于以特殊的空间分辨率对肿瘤微血管动力学进行床边评估。本研究评估了实时SR-US成像在肿瘤ICU急诊管理中监测肿瘤灌注变化的临床应用。方法:在这项前瞻性观察研究中,在紧急治疗(如皮质类固醇、减压或化疗)开始前后,对肿瘤急症的危重患者进行床边SR-US成像。采用SR-US定量微血管参数,包括灌注密度和血流异质性。数据处理采用人工智能进行实时船舶分割和定量分析。结果:SR-US成像成功地在治疗开始的几个小时内检测到灌注变化。肿瘤灌注减少与临床改善(包括症状缓解和缩短ICU住院时间)之间存在显著相关性。该技术可以可视化小至30微米的微血管,超越了传统超声的限制。使用造影剂微泡无不良事件报道。此外,SR-US成像减少了到放射科的运输需求,从而优化了ICU的工作流程。结论:实时SR-US成像为肿瘤急症急性期评估肿瘤血管反应提供了一种新颖的、床边兼容的方法。将其整合到ICU护理路径中可以提高及时决策,减少对静态成像的依赖,并支持个性化的癌症管理。需要进一步的多中心验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.80
自引率
2.90%
发文量
87
审稿时长
3 months
期刊介绍: Cancer Biotherapy and Radiopharmaceuticals is the established peer-reviewed journal, with over 25 years of cutting-edge content on innovative therapeutic investigations to ultimately improve cancer management. It is the only journal with the specific focus of cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapies. The Journal includes extensive reporting on advancements in radioimmunotherapy, and the use of radiopharmaceuticals and radiolabeled peptides for the development of new cancer treatments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信